Handmade quality · Free shipping over $75 · Explore the atelier

Ximelagatran 18647 Development and binding mode assessment

SKU: 22274950163

4.0
USD100.00 USD143.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4

Gentiopicrin

KDM4B-IN-B3 is also potent in inhibiting the growth of other cancer cell lines

Chemical Name: N-(5-(5-cyanothiophen-2-yl)-2-methylphenyl)-4-methylbenzenesulfonamide

Hederacolchiside A1 reduces the mitochondrial membrane potential and Bcl-2 protein levels

Ximelagatran 18647 Development and binding mode assessmentXimelagatran (H 376 95) is an orally active thrombin inhibitor that selectively and competitively inhibits both free and clot bound thrombin. Ximelagatran is an anticoagulant agent with a rapid onset of anticoagulant effect, predictable, dose dependent pharmcokinetics and pharmacodynamics. Product information CAS Number: 192939 46 1 Molecular Weight: 473. 57 Formula: C24H35N5O5 Chemical Name: ethyl 2 {[(1R) 1 cyclohexyl 2 [(2S) 2 [({4 [(Z) N'

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products